74 related articles for article (PubMed ID: 9488040)
41. Archaic structure of the gene encoding transcription factor USF.
Lin Q; Luo X; Sawadogo M
J Biol Chem; 1994 Sep; 269(39):23894-903. PubMed ID: 7523363
[TBL] [Abstract][Full Text] [Related]
42. Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains.
Luo X; Sawadogo M
Mol Cell Biol; 1996 Apr; 16(4):1367-75. PubMed ID: 8657110
[TBL] [Abstract][Full Text] [Related]
43. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose.
Vallet VS; Casado M; Henrion AA; Bucchini D; Raymondjean M; Kahn A; Vaulont S
J Biol Chem; 1998 Aug; 273(32):20175-9. PubMed ID: 9685363
[TBL] [Abstract][Full Text] [Related]
44. Tetramerization of upstream stimulating factor USF2 requires the elongated bent leucine zipper of the bHLH-LZ domain.
Huang C; Xia M; Qiao H; Liu Z; Lin Y; Sun H; Yu B; Fang P; Wang J
J Biol Chem; 2023 Oct; 299(10):105240. PubMed ID: 37690682
[TBL] [Abstract][Full Text] [Related]
45. USF2 inhibits the transcriptional activity of Smurf1 and Smurf2 to promote breast cancer tumorigenesis.
Tan Y; Chen Y; Du M; Peng Z; Xie P
Cell Signal; 2019 Jan; 53():49-58. PubMed ID: 30244169
[TBL] [Abstract][Full Text] [Related]
46. An auxiliary peptide required for the function of two activation domains in upstream stimulatory factor 2 (USF2) transcription factor.
Gourdon L; Lefrançois-Martinez AM; Viollet B; Martinez A; Kahn A; Raymondjean M
Genes Funct; 1997 Apr; 1(2):87-97. PubMed ID: 9680311
[TBL] [Abstract][Full Text] [Related]
47. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice.
Sirito M; Lin Q; Deng JM; Behringer RR; Sawadogo M
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3758-63. PubMed ID: 9520440
[TBL] [Abstract][Full Text] [Related]
48. Cyclin-Dependent Kinase 5 (CDK5)-Mediated Phosphorylation of Upstream Stimulatory Factor 2 (USF2) Contributes to Carcinogenesis.
Chi TF; Horbach T; Götz C; Kietzmann T; Dimova EY
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 31013770
[TBL] [Abstract][Full Text] [Related]
49. Vanadate can replace interleukin 3 for transient growth of factor-dependent cells.
Tojo A; Kasuga M; Urabe A; Takaku F
Exp Cell Res; 1987 Jul; 171(1):16-23. PubMed ID: 2442014
[TBL] [Abstract][Full Text] [Related]
50. Loss of USF2 promotes proliferation, migration and mitophagy in a redox-dependent manner.
Chi TF; Khoder-Agha F; Mennerich D; Kellokumpu S; Miinalainen I; Kietzmann T; Dimova EY
Redox Biol; 2020 Oct; 37():101750. PubMed ID: 33059314
[TBL] [Abstract][Full Text] [Related]
51. Translation and transcription: the dual functionality of LysRS in mast cells.
Yannay-Cohen N; Razin E
Mol Cells; 2006 Oct; 22(2):127-32. PubMed ID: 17085962
[TBL] [Abstract][Full Text] [Related]
52. v-H-ras gene reduces IL-3 requirement in PB-3c mastocytes in vitro followed by autokrine tumor formation in vivo.
Nair AP; Moroni C
Haematol Blood Transfus; 1987; 31():257-60. PubMed ID: 3502110
[No Abstract] [Full Text] [Related]
53. Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.
Horbach T; Götz C; Kietzmann T; Dimova EY
Front Pharmacol; 2015; 6():3. PubMed ID: 25741280
[TBL] [Abstract][Full Text] [Related]
54. Translational efficiency across healthy and tumor tissues is proliferation-related.
Hernandez-Alias X; Benisty H; Schaefer MH; Serrano L
Mol Syst Biol; 2021 Mar; 17(3):e10097. PubMed ID: 33759329
[TBL] [Abstract][Full Text] [Related]
55. Translation of Human β-Actin mRNA is Regulated by mTOR Pathway.
Eliseeva I; Vasilieva M; Ovchinnikov LP
Genes (Basel); 2019 Jan; 10(2):. PubMed ID: 30700035
[TBL] [Abstract][Full Text] [Related]
56. Nonconventional involvement of LysRS in the molecular mechanism of USF2 transcriptional activity in FcepsilonRI-activated mast cells.
Lee YN; Razin E
Mol Cell Biol; 2005 Oct; 25(20):8904-12. PubMed ID: 16199869
[TBL] [Abstract][Full Text] [Related]
57. Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2.
Giannola DM; Shlomchik WD; Jegathesan M; Liebowitz D; Abrams CS; Kadesch T; Dancis A; Emerson SG
J Exp Med; 2000 Nov; 192(10):1479-90. PubMed ID: 11085749
[TBL] [Abstract][Full Text] [Related]
58. Growth-dependent and PKC-mediated translational regulation of the upstream stimulating factor-2 (USF2) mRNA in hematopoietic cells.
Zhang ZC; Nechushtan H; Jacob-Hirsch J; Avni D; Meyuhas O; Razin E
Oncogene; 1998 Feb; 16(6):763-9. PubMed ID: 9488040
[TBL] [Abstract][Full Text] [Related]
59. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
60. Nuclear translocation of upstream stimulating factor 2 (USF2) in activated mast cells: a possible role in their survival.
Frenkel S; Kay G; Nechushtan H; Razin E
J Immunol; 1998 Sep; 161(6):2881-7. PubMed ID: 9743349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
